Apricus Misses Promised Drug Launch Target
01/02/2012
Apricus Misses Promised Drug Launch TargetTheStreet.comInstead, Apricus inked a small partnership for an experimental toenail fungus therapy. Separately, Apricus announced its intention to sell another $20 million in common stock, further diluting shareholders. In an email, Apricus spokesman Ed Cox said ...
01/02/2012
Apricus Misses Promised Drug Launch TargetTheStreet.comInstead, Apricus inked a small partnership for an experimental toenail fungus therapy. Separately, Apricus announced its intention to sell another $20 million in common stock, further diluting shareholders. In an email, Apricus spokesman Ed Cox said ...
Nail Fungus Nail Fungus Topical Treatments Toenail Fungus
No comments:
Post a Comment